Senores Pharmaceuticals begins operations at greenfield API facility
News

Senores Pharmaceuticals begins operations at greenfield API facility

This is Senores' second API manufacturing facility adding significantly to the existing API manufacturing capabilities.

  • By IPP Bureau | February 27, 2025

Senores Pharmaceuticals Limited (Senores) has inaugurated and commenced manufacturing activities at its greenfield Active Pharmaceutical Ingredient (API) plant located at Survey No. 1503, Rajpur, Kadi, Mehsana -382 715, Gujarat.

Spread across approximately 230,000 sq. ft. with an installed capacity of ~100 Metric Tons per Annum, this is Senores' second API manufacturing facility, adding significantly to the existing API manufacturing capabilities.

Commenting on the inauguration, Swapnil Shah, Managing Director, Senores Pharmaceuticals Limited said, "We are delighted to commence operations at our greenfield state-of-the-art API facility at Mehsana. Commissioning of this API facility will help Senores broaden its offerings and strengthen its competitiveness in the Regulated Markets, especially in the CDMO/CMO business."

Upcoming E-conference

Other Related stories

Startup

Digitization